Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Hepatitis C at epidemic levels among young injectors in London

12.11.2004


Levels of hepatitis C among young injecting drug users across London are reaching epidemic levels report researchers from Imperial College London, the Health Protection Agency and the London School of Hygiene and Tropical Medicine.



According to research published today in the British Medical Journal, four in ten new young injectors now has hepatitis C, while three per cent are now infected with HIV.

Hepatitis C, which can cause serious and sometimes fatal liver damage, is mainly spread by sharing needles and syringes. Preventing HCV transmission among injecting drug users is critical to avoiding significant later health consequences in the population and associated treatment costs.


Dr Ali Judd, from Imperial College London, based at Charing Cross Hospital, and one of the authors of the study, comments: “Hepatitis C is now spreading at epidemic levels across London and HIV incidence is worryingly high, which if unchecked will lead to an increase in the total number of HIV infections. There is an urgent need for new and comprehensive programmes to tackle this growing problem.”

For the study, the researchers recruited 428 injecting drug users, aged below 30 years or who had been injecting for six years or less, and followed them up one year later. The study was made possible through the use of saliva and blood spot tests for HCV and HIV developed at the Health Protection Agency Centre for Infections. Of those that were HCV negative or HIV negative at the first interview they found 42 percent and 3.4 percent were infected with HCV and HIV respectively one year later. The researchers also found high levels of syringe sharing, with one in four reporting injecting with needles and syringes that had been used by someone else in the last four weeks and one in two sharing other injecting paraphernalia.

Dr Matthew Hickman from Imperial College London, based at Charing Cross Hospital, and one of the authors of the study, comments: “For the past 6 or 7 years, government drug policy has focused on drugs and crime, and has been successful in expanding specialist drug treatment, especially through referral from criminal justice. However, there is a need now to re-invigorate harm reduction policies that prevent transmission of HCV and HIV.”

The researchers believe a number of factors may have contributed to the rise in the incidence of HCV and HIV. These include a rise in the number of injectors, without any increase in the number of syringes distributed through syringe programmes, more risky injecting behaviour in newer injecting drug users, and greater levels of crack injection. There has also been a lack of targeted health promotion campaigns about hepatitis C in recent years.

The study was funded by the Policy Research Programme of the Department of Health.

Tony Stephenson | alfa
Further information:
http://www.imperial.ac.uk

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>